This site is intended for U.S. audiences only.

IDHIFA® is a prescription medicine used to treat people with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation whose disease has come back or has not improved after previous treatment(s). It is not known if IDHIFA is safe and effective in children.

The page you are trying to access is not available.

You may have accessed this page via an outdated link or typed the URL incorrectly.

Go to the Home page to find what you are looking for.